Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
2020 North America Cancer Diagnostics Market Analysis: USA, Canada, Mexico-Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation
US$ 9,500.00
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as wel...
March 2020
630 pages
2020 World Cancer Diagnostics Market: Americas, EMEA, APAC-A 75-Country Analysis-Supplier Shares and Strategies by Test, Volume and Sales Segment Forecasts, Emerging Tumor Markers, Technologies and Instrumentation
US$ 45,000.00
This new 75-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executive...
March 2020
1450 pages
